TY - JOUR
T1 - Death of 43 Indonesian women with ovarian cancer
T2 - A case series
AU - Mulawardhana, Pungky
AU - Hartono, Poedjo
AU - Nugroho, Hari
AU - Ayuningtyas, Atika
N1 - Publisher Copyright:
© 2020 The Author(s)
PY - 2021/1
Y1 - 2021/1
N2 - Background: Ovarian cancer is a gynecological cancer with a higher mortality than other gynecological cancers. Case report: There were 43 cases of Indonesian women who died of ovarian cancer in 2015–2017. Patients were first diagnosed at the age of 40–59 years (65.11%), of which had normal BMI (62.72%) and mostly in stage III (39.53%). The histology was 88.3% epithelial ovarian cancer with the most subtypes of mucinous carcinoma (25.5%). The majority were referral patients (62.7%), but due to its malignancy, many died before receiving ovarian cancer treatment (40.74%). Of the 43 patients, 17 patients received chemotherapy, and 10 patients received a combination of surgical therapy and chemotherapy. Most of the deaths were caused by primary disease (69.77%). Patients with stages III and IV, as well as patients receiving surgery or chemotherapy alone had shorter survival times. Conclusion: Most ovarian cancer patients are first diagnosed at stage III with the mucinous carcinoma subtype. Most deaths are caused by primary ovarian cancer. The therapy that provides the longest survival is a combination of surgery and chemotherapy.
AB - Background: Ovarian cancer is a gynecological cancer with a higher mortality than other gynecological cancers. Case report: There were 43 cases of Indonesian women who died of ovarian cancer in 2015–2017. Patients were first diagnosed at the age of 40–59 years (65.11%), of which had normal BMI (62.72%) and mostly in stage III (39.53%). The histology was 88.3% epithelial ovarian cancer with the most subtypes of mucinous carcinoma (25.5%). The majority were referral patients (62.7%), but due to its malignancy, many died before receiving ovarian cancer treatment (40.74%). Of the 43 patients, 17 patients received chemotherapy, and 10 patients received a combination of surgical therapy and chemotherapy. Most of the deaths were caused by primary disease (69.77%). Patients with stages III and IV, as well as patients receiving surgery or chemotherapy alone had shorter survival times. Conclusion: Most ovarian cancer patients are first diagnosed at stage III with the mucinous carcinoma subtype. Most deaths are caused by primary ovarian cancer. The therapy that provides the longest survival is a combination of surgery and chemotherapy.
KW - Case series
KW - Indonesian woman
KW - Ovarian cancer
UR - http://www.scopus.com/inward/record.url?scp=85098998048&partnerID=8YFLogxK
U2 - 10.1016/j.ijscr.2020.12.067
DO - 10.1016/j.ijscr.2020.12.067
M3 - Short survey
AN - SCOPUS:85098998048
SN - 2210-2612
VL - 78
SP - 391
EP - 396
JO - International Journal of Surgery Case Reports
JF - International Journal of Surgery Case Reports
ER -